MSchulz Cartoons
@mschulzcartoons.bsky.social
Single-panel cartoon from a multi-channel buffoon.
PS, if you’re just here for the cartoons and wondering why I’m suddenly ranting about a nearly 200-year-old business law — surprise! I also moonlight as a tech nerd starting a small software-development venture. 🤓
November 16, 2025 at 3:32 AM
PS, if you’re just here for the cartoons and wondering why I’m suddenly ranting about a nearly 200-year-old business law — surprise! I also moonlight as a tech nerd starting a small software-development venture. 🤓
The way this post was written is driving me nuts. 🤣 Look at the first two sentences. 🤔
November 15, 2025 at 11:59 AM
The way this post was written is driving me nuts. 🤣 Look at the first two sentences. 🤔
Remember back in 2017 when hundreds of psychiatrists and psychologists publicly warned that Donald Trump’s grip on reality was… let’s call it “delicate”?
Pepperidge Farm remembers.
Pepperidge Farm remembers.
November 11, 2025 at 3:54 PM
Remember back in 2017 when hundreds of psychiatrists and psychologists publicly warned that Donald Trump’s grip on reality was… let’s call it “delicate”?
Pepperidge Farm remembers.
Pepperidge Farm remembers.
Legitimately thought this was a photo trolling Tr*mp. 😂
November 8, 2025 at 7:27 PM
Legitimately thought this was a photo trolling Tr*mp. 😂
Versailles 1789 vibes.
November 8, 2025 at 5:16 PM
Versailles 1789 vibes.
Agree in prinicple. 🙂 We could fund drug R&D publicly through taxes — that’s a valid model.
But the current U.S. system funds most drug development through shareholders taking on the financial risk.
So the question is which system we want, not whether the cost exists.
But the current U.S. system funds most drug development through shareholders taking on the financial risk.
So the question is which system we want, not whether the cost exists.
November 1, 2025 at 4:53 PM
Agree in prinicple. 🙂 We could fund drug R&D publicly through taxes — that’s a valid model.
But the current U.S. system funds most drug development through shareholders taking on the financial risk.
So the question is which system we want, not whether the cost exists.
But the current U.S. system funds most drug development through shareholders taking on the financial risk.
So the question is which system we want, not whether the cost exists.
It’s not that simple. The average cost of bringing a drug to market is $1.3B to $2.8B. You are only citing the manufacturing cost of a unit. When a company starts with a drug $2B in the red, it needs to make that back + profit to stay in business and, you know, develop the next drug society needs.
November 1, 2025 at 4:43 PM
It’s not that simple. The average cost of bringing a drug to market is $1.3B to $2.8B. You are only citing the manufacturing cost of a unit. When a company starts with a drug $2B in the red, it needs to make that back + profit to stay in business and, you know, develop the next drug society needs.